An experimental oral therapy called ifetroban proved generally safe and was well tolerated in adults with systemic sclerosis (SSc) over one year of treatment, according to top-line findings from a Phase 2a clinical trial. The trial, called ASSIST-SSc study (NCT02682511), compared once-daily ifetroban against a placebo in 41…
Discussion
A noninvasive imaging technique, which uses light to look at skin tissue over a wide area without actually touching it, can reliably measure the extent of scarring, or fibrosis, in people with systemic sclerosis (SSc) — and may work better than measurements now in use in which clinicians track…
Discussion
A noninvasive imaging tool called shear wave ultrasound elastography (SWE) helped detect increased muscle stiffness — specifically, a stiffer thigh muscle — in people with early systemic sclerosis (SSc), a study found. These results suggest that SWE — a technique that measures the stiffness or elasticity of tissues…
Becoming educated and informed about scleroderma is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your scleroderma journey.
There is no cure for scleroderma yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
